MarketsSingle-source
2.1
Vidrala reports 9% profit growth in H1 2026
ExpansiónLO·ES·1 day ago
Spanish biopharmaceutical company Almirall recorded a 49.4% increase in net profit for the first half of 2026 compared to the same period in 2025. The report reflects strong financial performance, though specific drivers for the growth were not detailed in the initial disclosure.